ANIP ANI PHARMACEUTICALS INC
Nasdaq · SEC CIK 1023024 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $14.87M 41 sales by 12 insiders
- Filings on record
- 320 since 2021-09-10, latest 2026-09-16 16:20
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Lalwani Nikhil | Pres, CEO, Dir | — | $5.05M |
| Walsh Patrick D | Dir | — | $2.32M |
| CAREY STEPHEN P. | SVP, CFO | — | $1.78M |
| Mutz Christopher | HEAD OF RARE DISEASE | — | $1.64M |
| Gassert Chad | SVP - CORP. DEV, STRATEGY | — | $1.31M |
| Davis Krista | SVP, Chief HR Off | — | $918.6K |
| Gutwerg Ori | SVP, GENERICS | — | $621.4K |
| Cook Meredith | SVP, GC, SEC | — | $453.9K |
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | — | $393.8K |
| HAUGHEY THOMAS | Dir | — | $161.8K |
Transactions 356
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 16:20 | 2026-09-15 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $71.00 | -5,400 | 339.1K | -2% | -$383.4K |
| T | 2026-09-14 20:57 | 2026-09-11 | ANIP | Thoma Jeanne | Dir | S - Sale | $71.53 | -1,000 | 26.8K | -4% | -$71.5K |
| T | 2026-09-14 20:56 | 2026-09-14 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $70.79 | -500 | 73.9K | -0.7% | -$35.4K |
| T | 2026-09-01 18:18 | 2026-08-31 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $72.80 | -2,850 | 171.8K | -2% | -$207.5K |
| 2026-08-27 16:21 | 2026-08-19 | ANIP | Gosebruch Henry O | Dir | A - Grant | $0.00 | +6,662 | 6,662 | New | $0 | |
| T | 2026-08-26 18:15 | 2026-08-25 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $74.30 | -5,400 | 344.5K | -2% | -$401.2K |
| T | 2026-08-13 16:32 | 2026-08-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $75.48 | -500 | 74.4K | -0.7% | -$37.7K |
| 2026-08-11 20:57 | 2026-08-10 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale | $77.00 | -3,162 | 75.5K | -4% | -$243.5K | |
| T | 2026-07-30 16:02 | 2026-07-29 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $81.36 | -2,850 | 174.7K | -2% | -$231.9K |
| 2026-07-21 16:32 | 2026-07-18 | ANIP | Cook Meredith | SVP, GC, SEC | F - Tax | $79.20 | -2,466 | 74.9K | -3% | -$195.3K | |
| T | 2026-07-14 16:02 | 2026-07-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $81.84 | -500 | 77.4K | -0.6% | -$40.9K |
| DT | 2026-07-06 21:40 | 2026-07-02 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,313 | 180.9K | +2% | +$164.0K |
| DT | 2026-07-06 21:40 | 2026-07-02 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $86.00 | -3,313 | 177.5K | -2% | -$284.9K |
| T | 2026-06-30 16:14 | 2026-06-29 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale | $84.12 | -2,850 | 177.5K | -2% | -$239.7K |
| T | 2026-06-15 18:44 | 2026-06-12 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $82.03 | -500 | 77.9K | -0.6% | -$41.0K |
| 2026-06-10 21:10 | 2026-05-21 | ANIP | Thoma Jeanne | Dir | A - Grant | $0.00 | +4,357 | 27.8K | +19% | $0 | |
| 2026-06-10 21:09 | 2026-05-21 | ANIP | TANNENBAUM RENEE P | Dir | A - Grant | $0.00 | +4,357 | 29.5K | +17% | $0 | |
| 2026-06-10 21:08 | 2026-05-21 | ANIP | Pera Antonio R | Dir | A - Grant | $0.00 | +4,357 | 27.0K | +19% | $0 | |
| 2026-06-10 21:08 | 2026-05-21 | ANIP | Leonard Matthew J | Dir | A - Grant | $0.00 | +4,357 | 11.2K | +63% | $0 | |
| T | 2026-06-10 21:06 | 2026-05-21 | ANIP | HAUGHEY THOMAS | Dir | A - Grant | $0.00 | +4,357 | 40.9K | +12% | $0 |
| T | 2026-06-10 21:06 | 2026-06-08 | ANIP | HAUGHEY THOMAS | Dir | S - Sale | $80.88 | -2,000 | 38.9K | -5% | -$161.8K |
| DT | 2026-06-09 18:33 | 2026-06-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,312 | 183.7K | +2% | +$164.0K |
| DT | 2026-06-09 18:33 | 2026-06-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $80.00 | -3,312 | 180.4K | -2% | -$265.0K |
| M | 2026-05-13 20:22 | 2026-05-11+ | ANIP | Walsh Patrick D | Dir | S - Sale | $80.66 | -14.0K | 38.4K | -27% | -$1.13M |
| 2026-05-13 16:16 | 2026-05-12 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S - Sale | $79.21 | -459 | 38.3K | -1% | -$36.4K | |
| 2026-05-13 16:16 | 2026-05-11 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | S - Sale | $77.57 | -55.0K | 349.9K | -14% | -$4.27M | |
| 2026-05-13 16:15 | 2026-05-12 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale | $79.50 | -2,772 | 78.7K | -3% | -$220.4K | |
| T | 2026-05-13 16:15 | 2026-05-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $78.16 | -500 | 78.4K | -0.6% | -$39.1K |
| T | 2026-04-13 16:40 | 2026-04-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $77.95 | -500 | 78.9K | -0.6% | -$39.0K |
| 2026-03-13 | 2026-03-11 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | S - Sale | $74.91 | -4,772 | 38.7K | -11% | -$357.5K | |
| 2026-03-13 | 2026-03-13 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $71.64 | -3,162 | 91.3K | -3% | -$226.5K | |
| 2026-03-13 | 2026-03-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $72.62 | -500 | 79.4K | -0.6% | -$36.3K | |
| M | 2026-03-10 | 2026-03-06+ | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $74.19 | -5,723 | 94.5K | -6% | -$424.6K |
| 2026-03-10 | 2026-03-07 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $74.04 | -3,314 | 98.1K | -3% | -$245.4K | |
| 2026-03-10 | 2026-03-07 | ANIP | CAREY STEPHEN P. | SVP, CFO | F - Tax | $74.04 | -5,150 | 180.4K | -3% | -$381.3K | |
| 2026-03-10 | 2026-03-07 | ANIP | Gutwerg Ori | SVP, GENERICS | F - Tax | $74.04 | -3,314 | 81.5K | -4% | -$245.4K | |
| M | 2026-03-10 | 2026-03-06+ | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $74.33 | -6,572 | 51.9K | -11% | -$488.5K |
| 2026-03-10 | 2026-03-07 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $74.04 | -17.1K | 404.9K | -4% | -$1.26M | |
| DM | 2026-03-05 | 2026-03-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $75.50 | -7,312 | 189.5K | -4% | -$552.0K |
| D | 2026-03-05 | 2026-03-05 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $49.51 | +3,312 | 192.9K | +2% | +$164.0K |
| 2026-03-04 | 2026-03-03 | ANIP | Gutwerg Ori | SVP, GENERICS | S - Sale | $76.50 | -2,060 | 84.8K | -2% | -$157.6K | |
| 2026-03-04 | 2026-03-02 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $74.00 | -417 | 103.5K | -0.4% | -$30.9K | |
| 2026-03-03 | 2026-03-03 | ANIP | Walsh Patrick D | Dir | S - Sale | $74.23 | -6,000 | 52.4K | -10% | -$445.4K | |
| 2026-03-02 | 2026-02-26 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | A - Grant | $77.15 | +11.1K | 101.1K | +12% | +$857.6K | |
| 2026-03-02 | 2026-02-26 | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | A - Grant | $77.15 | +11.1K | 77.1K | +17% | +$857.6K | |
| 2026-03-02 | 2026-02-28 | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | F - Tax | $73.90 | -2,221 | 74.9K | -3% | -$164.1K | |
| 2026-03-02 | 2026-02-26 | ANIP | Cook Meredith | SVP, GC, SEC | A - Grant | $77.15 | +13.9K | 81.4K | +21% | +$1.07M | |
| 2026-03-02 | 2026-02-28 | ANIP | Cook Meredith | SVP, GC, SEC | F - Tax | $73.90 | -1,555 | 79.9K | -2% | -$114.9K | |
| 2026-03-02 | 2026-02-26 | ANIP | Davis Krista | SVP, Chief HR Off | A - Grant | $77.15 | +10.8K | 60.1K | +22% | +$834.0K | |
| 2026-03-02 | 2026-02-28 | ANIP | Davis Krista | SVP, Chief HR Off | F - Tax | $73.90 | -1,555 | 58.5K | -3% | -$114.9K | |
| 2026-03-02 | 2026-02-28 | ANIP | CAREY STEPHEN P. | SVP, CFO | F - Tax | $73.90 | -2,773 | 189.5K | -1% | -$204.9K | |
| 2026-03-02 | 2026-02-26 | ANIP | CAREY STEPHEN P. | SVP, CFO | A - Grant | $77.15 | +22.2K | 192.3K | +13% | +$1.72M | |
| 2026-03-02 | 2026-02-26 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A - Grant | $77.15 | +6,021 | 44.1K | +16% | +$464.5K | |
| 2026-03-02 | 2026-02-28 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $73.90 | -628 | 43.5K | -1% | -$46.4K | |
| 2026-03-02 | 2026-02-26 | ANIP | Gutwerg Ori | SVP, GENERICS | A - Grant | $77.15 | +13.0K | 89.1K | +17% | +$1.00M | |
| 2026-03-02 | 2026-02-28 | ANIP | Gutwerg Ori | SVP, GENERICS | F - Tax | $73.90 | -2,221 | 86.8K | -2% | -$164.1K | |
| 2026-03-02 | 2026-02-28 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $73.90 | -12.2K | 421.9K | -3% | -$902.8K | |
| 2026-03-02 | 2026-02-26 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $77.15 | +75.6K | 434.2K | +21% | +$5.83M | |
| 2026-03-02 | 2026-02-26 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | A - Grant | $77.15 | +21.3K | 106.1K | +25% | +$1.64M | |
| 2026-03-02 | 2026-02-28 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $73.90 | -2,221 | 103.9K | -2% | -$164.1K | |
| M | 2026-02-23 | 2026-02-19+ | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $77.74 | -3,814 | 51.0K | -7% | -$296.5K |
| 2026-02-23 | 2026-02-20 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $78.02 | -5,323 | 84.8K | -6% | -$415.3K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | F - Tax | $77.04 | -3,325 | 66.0K | -5% | -$256.2K |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $77.01 | -22.0K | 358.6K | -6% | -$1.69M |
| M | 2026-02-17 | 2026-02-12+ | ANIP | CAREY STEPHEN P. | SVP, CFO | F - Tax | $77.01 | -5,277 | 172.5K | -3% | -$406.4K |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Davis Krista | SVP, Chief HR Off | F - Tax | $77.04 | -2,470 | 53.1K | -4% | -$190.3K |
| 2026-02-17 | 2026-02-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $76.80 | -500 | 69.3K | -0.7% | -$38.4K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Cook Meredith | SVP, GC, SEC | F - Tax | $77.05 | -3,313 | 67.5K | -5% | -$255.3K |
| 2026-02-17 | 2026-02-12 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | S - Sale | $76.55 | -7,032 | 92.6K | -7% | -$538.3K | |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $76.98 | -5,576 | 90.2K | -6% | -$429.3K |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Gutwerg Ori | SVP, GENERICS | F - Tax | $77.04 | -3,663 | 78.0K | -4% | -$282.2K |
| M | 2026-02-17 | 2026-02-12+ | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $77.00 | -1,051 | 38.6K | -3% | -$80.9K |
| 2026-02-13 | 2026-02-11 | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | F - Tax | $76.25 | -2,898 | 89.9K | -3% | -$221.0K | |
| 2026-02-13 | 2026-02-11 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | F - Tax | $76.25 | -30.7K | 380.6K | -7% | -$2.34M | |
| 2026-02-13 | 2026-02-11 | ANIP | Cook Meredith | SVP, GC, SEC | F - Tax | $76.25 | -3,011 | 71.4K | -4% | -$229.6K | |
| 2026-02-13 | 2026-02-11 | ANIP | Gutwerg Ori | SVP, GENERICS | F - Tax | $76.25 | -4,267 | 79.8K | -5% | -$325.4K | |
| 2026-02-13 | 2026-02-11 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $76.25 | -1,762 | 39.2K | -4% | -$134.4K | |
| 2026-02-13 | 2026-02-11 | ANIP | Mutz Christopher | HEAD OF RARE DISEASE | F - Tax | $76.25 | -4,546 | 102.8K | -4% | -$346.6K | |
| 2026-02-13 | 2026-02-11 | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | F - Tax | $76.25 | -4,269 | 69.3K | -6% | -$325.5K | |
| 2026-02-13 | 2026-02-11 | ANIP | Davis Krista | SVP, Chief HR Off | F - Tax | $76.25 | -3,017 | 55.5K | -5% | -$230.0K | |
| 2026-02-13 | 2026-02-11 | ANIP | CAREY STEPHEN P. | SVP, CFO | F - Tax | $76.25 | -5,503 | 175.4K | -3% | -$419.6K | |
| 2026-01-14 | 2026-01-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $84.33 | -500 | 74.4K | -0.7% | -$42.2K | |
| 2025-12-19 | 2025-12-18 | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $82.40 | -1,622 | 58.6K | -3% | -$133.7K | |
| 2025-12-12 | 2025-12-12 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $82.32 | -400 | 74.9K | -0.5% | -$32.9K | |
| 2025-12-09 | 2025-12-05 | ANIP | TANNENBAUM RENEE P | Dir | S - Sale | $81.15 | -1,800 | 25.2K | -7% | -$146.1K | |
| 2025-11-17 | 2025-11-13 | ANIP | Walsh Patrick D | Dir | G - Gift | $0.00 | -3,000 | 58.4K | -5% | $0 | |
| 2025-11-17 | 2025-11-13 | ANIP | Walsh Patrick D | Dir | S - Sale | $86.88 | -8,643 | 61.4K | -12% | -$750.9K | |
| MI | 2025-11-14 | 2025-11-12+ | ANIP | Gassert Chad | SVP - CORP. DEV, STRATEGY | S - Sale | $89.06 | -14.7K | 158.5K | -9% | -$1.31M |
| 2025-11-14 | 2025-11-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $87.27 | -400 | 75.3K | -0.5% | -$34.9K | |
| 2025-10-14 | 2025-10-13 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $90.09 | -400 | 75.7K | -0.5% | -$36.0K | |
| 2025-09-22 | 2025-09-19 | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $98.04 | -1,000 | 60.2K | -2% | -$98.0K | |
| 2025-09-15 | 2025-09-12 | ANIP | Cook Meredith | SVP, GC, SEC | S - Sale | $98.42 | -400 | 76.1K | -0.5% | -$39.4K | |
| 2025-09-15 | 2025-09-12 | ANIP | Davis Krista | SVP, Chief HR Off | F - Tax | $97.71 | -1,710 | 61.2K | -3% | -$167.1K | |
| 2025-09-04 | 2025-09-03 | ANIP | Pera Antonio R | Dir | S - Sale | $94.94 | -7,292 | 22.7K | -24% | -$692.3K | |
| 2025-08-26 | 2025-08-25 | ANIP | Leonard Matthew J | Dir | S - Sale | $90.62 | -2,528 | 6,864 | -27% | -$229.1K | |
| 2025-08-25 | 2025-08-22 | ANIP | Davis Krista | SVP, Chief HR Off | S - Sale | $91.10 | -1,763 | 62.9K | -3% | -$160.6K | |
| MI | 2025-08-22 | 2025-08-20+ | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $90.36 | -100.0K | 431.9K | -19% | -$9.04M |
| M | 2025-08-20 | 2025-08-18 | ANIP | Thoma Jeanne | Dir | S - Sale | $89.15 | -21.5K | 23.4K | -48% | -$1.92M |
| 2025-08-20 | 2025-08-20 | ANIP | Pera Antonio R | Dir | S - Sale | $89.73 | -5,421 | 30.0K | -15% | -$486.4K | |
| MI | 2025-08-18 | 2025-08-14+ | ANIP | Shanmugam Muthusamy | HEAD OF R, D, COO-NOVITIUM OPS, Dir | S - Sale | $88.25 | -100.0K | 531.9K | -16% | -$8.82M |
Purchase Sale Sale after option exercise All abbreviations